iifl-logo

SBI Healthcare Opportunities Fund G

SBI Healthcare Opportunities Fund G

Fund Name

SBI Mutual Fund

Scheme Name

SBI Healthcare Opportunities Fund G

AMC

SBI Mutual Fund

Type

:  Open

Category

Equity - Pharma

Launch Date

04-Jun-1999

Fund Manager

Tanmaya Desai

Net Assets (Rs. cr)

4323.29

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

SBI Healthcare Opportunities Fund G - Nav Details

Nav Date

:  27-May-2026

NAV [Rs.]

:  -

Buy/Resale Price [Rs.]

-

Sell/Repurchase Price [Rs.]

-

Entry Load %

Exit Load %

SBI Healthcare Opportunities Fund G- NAV Chart

SBI Healthcare Opportunities Fund G- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
0.38
9.25
8.11
7.95
11.56
26.09
15.63
15.3
Category Avg
0.32
8.05
7.68
6.98
11.75
25.72
14.57
15.44
Category Best
1.5
10.14
10.32
12.07
20.98
30.02
17.19
29.84
Category Worst
-0.84
3.36
1.08
-0.84
3.09
21.17
11.01
0.58

SBI Healthcare Opportunities Fund G- Latest Dividends

No Records Found

SBI Healthcare Opportunities Fund G- Investment Details

Min. Investment(Rs.)

5000

Increm.Investment(Rs.)

1000

In & Out

In

InName Of The CompanyNo Of Shares
--

Out

InName Of The CompanyNo Of Shares
Vijaya Diagnost.2,50,000
Corona Remedies75,000

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology11.712800000506.32
EquityDivi's Lab.Pharmaceuticals & Biotechnology6.77450000292.61
EquityAcutaas ChemicalPharmaceuticals & Biotechnology5.40900000233.46
EquityApollo HospitalsHealthcare Services5.30300000229.09
EquityMax HealthcareHealthcare Services5.172250000223.43
EquityAster DM Health.Healthcare Services3.892400000168.25
EquityLupinPharmaceuticals & Biotechnology3.84720000165.97
EquityTorrent Pharma.Pharmaceuticals & Biotechnology3.48360000150.66
EquityAnthem BiosciencPharmaceuticals & Biotechnology3.451962504149.16
EquityAether Industri.Chemicals & Petrochemicals3.351235202144.74
EquityMankind PharmaPharmaceuticals & Biotechnology3.33640000143.78
EquityAurobindo PharmaPharmaceuticals & Biotechnology3.211000000138.95
EquityFortis Health.Healthcare Services3.201500000138.44
EquityBioconPharmaceuticals & Biotechnology3.123750000134.86
EquityLaurus LabsPharmaceuticals & Biotechnology3.061200000132.11
Foreign EquityLonza GroupPharmaceuticals & Biotechnology2.71200000117.01
EquityJupiter Life LinHealthcare Services2.55900000110.33
EquityAlkem LabPharmaceuticals & Biotechnology2.50200000108.00
EquitySai LifePharmaceuticals & Biotechnology2.471000000106.94
EquityKrishna Institu.Healthcare Services2.471600000106.67
EquityGland PharmaPharmaceuticals & Biotechnology2.43600000105.04
EquityPoly MedicureHealthcare Equipment & Supplies2.2464000096.77
EquitySudeep PharmaChemicals & Petrochemicals2.23136000096.22
EquityAjanta PharmaPharmaceuticals & Biotechnology1.9630000084.68
EquityConcord BiotechPharmaceuticals & Biotechnology1.9072000082.22
EquityAbbott IndiaPharmaceuticals & Biotechnology1.472500063.58
EquityCohance LifePharmaceuticals & Biotechnology1.12100000048.32
EquityNephrocare HealtHealthcare Services0.9880000042.34
EquityRainbow Child.Healthcare Services0.8730000037.56
EquityGufic BioSciencePharmaceuticals & Biotechnology0.4670474120.05
EquitySanofi ConsumerPharmaceuticals & Biotechnology0.444000019.05
EquityMedplus HealthRetailing0.3015000013.08

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
SBI Mutual Fund
Incorporation Date:
07-Feb-1992
Total Assets Managed (Cr.):
12,70,599.37
Trustee/s:
Sandra Martyres, Bharati Rao, Smt. Manju Agarwal, SBI Mutual Fund Trustee C, Richard Mendonca, Mr. Dhruv Prakash
Chairman:
NA
CEO / MD:
Nand Kishore
CIO:
NA
President:
NA
Director/s:
Om Prakash Gahrotra, Dr. Prafulla Agnihotri, Mrs. Madhu Dubhashi
Compliance Officer/s:
NA
Investor Service Officer/s:
NA
Fund Manager/s:
Tanmaya Desai
Auditors:
Sudit K Parekh & Co, M/S Chandabhoy&Jassoobhoy

OTHER INFORMATION

Registered Office:
9th Floor,Crescenzo, C-39&39, G Block, Bandra kurla complex, Bandra (east), Mumbai-400 051.
Contact Nos:
022-61793000
Fax:
022-67425687
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.